DEA scheduling is compound-specific and depends on the derivative's chemical structure and pharmacological profile. Importers should submit a scheduling inquiry to DEA's Diversion Control Division or obtain a formal scheduling determination before the first shipment. Importing an unscheduled analog that DEA later determines is a controlled substance analog can trigger enforcement action under the Federal Analogue Act.

Singapore hosts a number of specialty fine-chemical and pharmaceutical contract manufacturing operations that serve as regional hubs for Asian and global supply chains. These facilities often source precursor materials from elsewhere in Asia, perform final synthesis or purification, and export finished intermediates to the US market. The Singapore origin reflects this hub-and-spoke manufacturing model rather than domestic raw-material production.